Navigation Links
Icahn Confirms Intention to Nominate Three Directors at Biogen
Date:1/28/2008

NEW YORK, Jan. 28 /PRNewswire/ -- Carl Icahn confirmed today that entities affiliated with him have given notice to Biogen Idec that they intend to nominate three persons at Biogen's forthcoming 2008 Annual Meeting of Stockholders to serve as directors of Biogen. Biogen currently has a staggered board of twelve directors, and there are four directorships up for election this year.

Mr. Icahn stated that "We are taking this action because we believe that Biogen's recent purported attempt to find a suitor was not conducted in a way to enhance the success of the endeavor. We believe that the process was flawed in a number of key respects and that the process was run to placate us and other large shareholders who we believe asked for Biogen to find a buyer.

"It has been reported in the press that Biogen refused to allow potential bidders to talk to Elan Pharmaceuticals, Biogen's partner on the key pharmaceutical product Tysabri. Elan has some change-of-control rights on Tysabri. Although Elan has indicated that they would not invoke change-of-control rights, obviously, any prospective bidder would want to talk to Elan directly about change-of-control issues as well as discuss the growth trajectory for Tysabri. Incredibly, Biogen prevented any bidder from talking to Elan about anything unless they made a 'binding proposal' as reported in the Financial Times on January 21, 2008."

Mr. Icahn also stated, "We also believe that the confidentiality agreement was so restrictive that certain potential bidders were not able to sign the agreement and therefore were not able to participate in the bidding."

Mr. Icahn also pointed out that after Biogen announced that it was ending the sale process, Jim Mullen, CEO of Biogen, was quoted in the Financial Times as saying that Biogen might make a large scale acquisition. He is quoted as saying, "We could spend 10 billion dollars." Mr. Icahn indicated that he is quite concerned and believes all Biogen sha
'/>"/>

SOURCE Icahn
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Barr Confirms Patent Challenge of Namenda(R) Tablets, 5mg & 10mg
2. Barr Confirms Patent Challenge of Eloxatin(R) Injectable, 5mg/mL
3. Barr Confirms Patent Challenge of Focalin(R) XR
4. Recent Study Confirms Alimentary Healths Bifantis(R) Demonstrates Efficacy in the Treatment of Irritable Bowel Syndrome
5. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
6. Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product
7. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
8. BioMS Medical announces its intention to renew a normal course issuer bid
9. Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hill Press Conference
10. Roche to Nominate Independent Directors for Election at Ventanas 2008 Annual Stockholders Meeting
11. SDCRM Receives Highest Score in Three of Four Categories from CIRM on Part I of Major Facilities Grant Application

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... A new generation of ultrasmall transistors and mo...alled semiconducting nanowires are closer to reali...rdue University and the University of California a...w to create nanowires with layers of different mat...l, which is a critical requirement for making effi...
(Date:11/25/2009)... ,, BOCA RATON, Fla., Nov. 25 /PRNewswire/ -...r. Not so for BodyLogicMD. The nation,s largest a...ecializing exclusively in medically supervised bi...hysicians in its network since November 2008 - ...add more physician-owned centers, including one in...
(Date:11/25/2009)... 25 Ardea Biosciences, I... Quart, Pharm.D., president and chief executive of...al Health Care Conference. , ,Presentation detail...h Care Conference,Date: Tuesday, December 1, ...The New York Palace Hotel, New York, NY,Webcast: ...
(Date:11/24/2009)...e New York investment bank KTA Capital,s client Ne...U$6.7 mil convertible note private placement with ...nt was arranged by KTA Capital as Neuren,s exclusi... New York (PRWEB) November 23, 2009 -- The... LLC ("KTA Capital") has announced that ...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...ZHOU, China, Sept. 17 /Xinhua-PRNewswire/ -- Shand...tin Board: SZSN) ("SZSN" or "Parent,Corporation") ...nounced,that its operating subsidiary company in C... ("Zhouyuan" or "the Company"), had signed a new s...n Seeds Co., Ltd. ("Kun Yuan") on,August 6, 2007. ...
...SEGUNDO, Calif., Sept. 17 DaVita Inc.,(NYSE: DVA... Best of,Americas Conference in London on Thursday...tp://www.newscom.com/cgi-bin/prnh/20020729/DAVITAL...ww.ibb.ubs.com, click on the,Conferences icon in ...nk,listed next to the relevant conference title. T...
...ILTON, Bermuda, Sept. 17 Warner Chilcott,Limited .../S ("LEO") has,received a non-final Action Closing...fice (the "USPTO"). In September 2006, the USPTO o...3,013 (the "013 Patent") in,response to a request ...EX,and certain of LEO,s products in development. W...
Other Biology Technology:Shandong Zhouyuan Seed and Nursery Co., Ltd. Signs an Agreement with Linyi Company 2Shandong Zhouyuan Seed and Nursery Co., Ltd. Signs an Agreement with Linyi Company 3Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent 2Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent 3
(Date:11/24/2009)...Stents that keep weakened and flabby arteries from...six months, those stents are no longer needed -- o...ecessary. Previously, doctors had no choice but to...f Tel Aviv University,s Department of Biomedical E...r platform that carries drugs where they,re needed...
(Date:11/24/2009)... What constitutes fish food is a matter of debate....at fish get almost 50 percent of their carbon from...between the terrestrial and aquatic ecosystems. ,...on shows this is not likely to be true. Algae prov...life, according to research published this week in...
(Date:11/23/2009)..., Cambridge, Mass. November 23, 2009 Applied m...tain lily ( Hosta lancifolia ), a characteristic l...sely packed ripples along the edges. The simple ca... resulting from bending during differential growth... stretching foam ribbons. , Haiyi Liang, a postd...
Breaking Biology News(10 mins):A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The cause behind the characteristic shape of a long leaf revealed 2UD start up company prepares to commercialize novel detector for medical military applications 10557 1UD start up company prepares to commercialize novel detector for medical military applications 10557 2UD start up company prepares to commercialize novel detector for medical military applications 10557 3UD start up company prepares to commercialize novel detector for medical military applications 10557 4Meditation May Reduce Stress in Breast Cancer Patients 60245 1Meditation May Reduce Stress in Breast Cancer Patients 60245 2GCI ConnectMD Links Swedish Medical Center Neuroscience Stroke Specialists and Patients Throughout Washington State to Swedish 26apos 3Bs Joint Commis 60243 1GCI ConnectMD Links Swedish Medical Center Neuroscience Stroke Specialists and Patients Throughout Washington State to Swedish 26apos 3Bs Joint Commis 60243 2GCI ConnectMD Links Swedish Medical Center Neuroscience Stroke Specialists and Patients Throughout Washington State to Swedish 26apos 3Bs Joint Commis 60243 3
... found a family of proteins that enhances the sens...normal growth and cancer. Their discovery could le...ancers and the development of new drugs to stop un...s. , The researchers at the University of Oxford, ... Sciences Research Council (BBSRC), discovered tha...
...ed, partial correction to bleeding problems in mic...help with the development of gene therapy treatmen...mp on the knee can cause serious internal bleeding...a Roy J. and Lucille A. Carver College of Medicine... therapy to cells -- in two ways to create a susta...
...s and muscle weakness during sport because the bra... movement, Monash University researchers have foun...nt of Physiology, found when muscles were weakened...d, particularly if the person couldn,t see their l... Journal of Physiology, showed muscles needed to w...
Other Biology News:Fruit fly studies open new window on cancer research 2Gene therapy advance treats hemophilia in mouse models 2Gene therapy advance treats hemophilia in mouse models 3Can't serve an ace? Could be muscle fatigue 2
BD BioCoat Osteologic 12 mm round Coverslips from BD Biosciences - Discovery Labware
...tibiotic that inhibits N-linked glycosylation and ...hydrate linkages. Active in vitro against Gram-p...bits the expression of functional thrombin recepto...thrombin-induced Ca 2+ mobilization in cells. Pu...
...s used for agitation and mixing applications such ...ng and destaining of gels and blots, and Southern ...control (8-40 rpm) and can handle a maximum load o...cm platforms covered with nonsolid rubber mats tha...
Mouse Anti-Human DCAMKL2 Monoclonal Antibody, Unconjugated, Clone 2A5 from Novus Biologicals
Biology Products: